InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Pauls Dietrich John, Chairman & CEO. Insider active across 1 company, notably DiaMedica Therapeutics Inc.. Cumulatively, 4 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €82k. History available since 16 August 2021. The latest transaction was disclosed on 10 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
John Pauls is the President and CEO of DiaMedica Therapeutics Inc., a biopharmaceutical company. In his role, he is responsible for the strategic direction of the company and the management of its operations. With experience in the biopharmaceutical sector, he plays a key role in developing new treatments and driving innovation.